Evaluation of the effectiveness of botulinum toxin injections in the lower limb muscles of children with cerebral palsy. Preliminary prospective study of the advantages of ultrasound guidance

Annals of Physical and Rehabilitation Medicine

Volumn 52, Issue 3, 2009, Pages 215-223

  Py, A G ^a   Zein Addeen, G ^a   Perrier, Y ^b   Carlier, R Y ^b   Picard, A ^a  

^a HÔpital Raymond Poincaré   (France)

^b RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

Botulinum toxin; Cerebral palsy; Children; Effectiveness; Ultrasound guidance

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ARTICLE; ASTHENIA; CEREBRAL PALSY; CHILD; CLINICAL EXAMINATION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GASTROCNEMIUS MUSCLE; GROUPS BY AGE; HAMSTRING; HUMAN; INJECTION SITE; JUMPING; LEG MUSCLE; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; RUNNING; SOLEUS MUSCLE; TREATMENT RESPONSE; ULTRASOUND; WALKING;

ADOLESCENT; BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 67349207335     PISSN: 18770657     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rehab.2009.02.005     Document Type: Article

References (29)

1. Bertrand H., and Forin V. Toxine botulinique type A chez l'enfant : évaluation des indications à partir d'une revue de la littérature. Ann Readapt Med Phys 46 (2003) 346-352
2. Berweck S. Sonography-guided injection of botulinum toxin in children with cerebral palsy. Lancet 363 (2004) 249-250
3. Berweck S., Feldkamp A., Francke A., Nehles J., Schwerin A., and Heinen F. Sonography-guided injection of botulinum toxin a in children with cerebral palsy. Neuropediatrics 33 (2002) 221-223
4. Boyd R.N., and Hays R.M. Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review. Eur J Neurol 8 suppl. 5 (2001) 1-20
5. Carr L.J., Cosgrove A.P., Gringras P., Neville B.G.R., et al. Position paper on the use of botulinum toxin in cerebral palsy. Arch Dis Child 79 (1998) 271-273
6. Chin T., Nattrass G.R., Selber P., and Graham H.K. Accuracy of intramuscular injection of botulinum toxin a in juvenile cerebral palsy. a comparison between manual needle placement and placement guided by electrical stimulation. J Pediatr Orthop 25 (2005) 286-291
7. Cosgrove A.P., Corry I.S., and Graham H.K. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 36 (1994) 386-396
8. Desloovere K., Molenaers G., De Cat J., Pauwels P., Van Campenhout A., and Ortibus E. Motor function following multilevel botulinum toxin type A treatment in children with cerebral palsy. Dev Med Child Neurol 49 (2007) 56-61
9. Filipetti P., and Chantraine F. Utilisation de fortes doses de toxine botulique de type A chez l'enfant : intérêt et sécurité en pratique clinique. Ann Readapt Med phys 50 suppl. 1 (2007) S7-S11
10. Galli M., Crivellini M., Santambrogio G.C., Fazzi E., and Motta F. Short-term effects of « botulinum toxin A » as treatment for children with cerebral palsy: kinematic and kinetic aspects at the ankle joint. Funct Neurol 16 (2001) 317-323
11. Gracies J.M. Évaluation de la spasticité. Apport de l'échelle de Tardieu. Motr Cereb 22 (2001) 1-16
12. Graham H.K., Aoki K.R., Autti-Rämo I., Boyr R.N., Delgado M.R., Gaebler-Spira D.J., et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 11 (2000) 67-79
13. Groupe VARAX (2005). Guide de l'examen Clinique neuromoteur de l'enfant infirme motor cerebral (ed) .Sauramps Montpellier.
14. Koman A., Brashear A., Rosenfeld S., Chambers H., Russman B., Rang M., et al. Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial. Pediatrics 108 (2001) 1062-1071
15. Koman L.A., Mooney III J.F., Smith B., Goodman A., and Mulvaney T. Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop 13 (1993) 489-495
16. Koman L.A., Mooney J.F., Smith B.P., Walker F., Leon J.M., et al. Botulinum toxin type a neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. J Ped Orthop 20 (2000) 108-115
17. Mall V., Heinen F., Kirschner J., Linder M., Stein S., Michaelis U., et al. Evaluation of botulinum toxin a therapy in children with adductor spasm by gross motor function measure. J Child Neurol 15 (2000) 214-217
18. Mall V., Heinen F., Siebel A., Bertram C., Hafkemeyer U., Wissel J., et al. Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study. Dev Med Child Neurol 48 (2006) 10-13
19. Molenaers G., Desloovere K., Eyssen M., Decat J., Jonkers I., and De Cock P. Botulinum toxin type A treatment of cerebral palsy: an integrated approach. Eur J Neurol 6 suppl. 4 (1999) S51-S57
20. Russell D., Rosenbaum P., Cadman D., Gowland C., Hardy S., and Jarvis S. The Gross Motor Function Measure: a means to evaluate the effects of physical therapy. Dev Med Child Neurol 31 (1989) 341-352
21. Russell D., Rosenbaum P., et al. EMFG : evaluation motrice fonctionnelle globale (1997), Handicap International, Lyon
22. Schlachter K., Endres G., and Huemer C.H. Sonography-guided injections of botulinum toxin type A in spastic muscles in childhood. Dev Med Child Neurol 48 suppl. 107 (2006) 17-18 ABS
23. Scholtes V.A., Dallmeijer A.J., Knol D.L., Speth L.A., Maathuis C.G., Jongerius P.H., et al. The combined effect of lower-limb multilevel botulinum toxin type a and comprehensive rehabilitation on mobility in children with cerebral palsy: a randomized clinical trial. Arch Phys Med Rehabil 87 (2006) 1551-1558
24. Scholtes V.A., Dallmeijer A.J., Knol D.L., Speth L.A., Maathuis C.G., Jongerius P.H., et al. Effect of multilevel toxin a and comprehensive rehabilitation on gait in cerebral palsy. Pediatr Neurol 36 (2007) 30-39
25. Sutherland D.H., Kaufman K.R., Wyatt M.P., Chambers H.G., and Mubarak S.J. Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture 10 (1999) 1-9
26. Ubhi T., et al. Randomized double blind placebo controlled trail of the effect of Botulinum toxin on walking in cerebral palsy. Arch Dis Child 83 (2000) 481-487
27. Willenborg M.J., Shilt J.S., Smith B.P., Estrada R.L., Castle J.A., and Koman L.A. Technique for Iliopsoas ultrasound-guided active electromyography-directed botulinum a toxin injection in cerebral palsy. J Ped Orthop 22 (2002) 165-168
28. Willis A.W., Crowner B., Brunstrom J.E., Kissel A., and Racette B.A. High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy. Dev Med Child Neurol 49 (2007) 818-822
29. Wissel J., Heinen F., Schenkel A., Doll B., Ebersbach G., Müller J., et al. Botulinum Toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment. Neuropediatrics 30 (1999) 120-124